Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate
Globe Newswire22-07-2024, 17:00
New Appointee Joins Citizens Coinage Advisory Committee 9-02-2023, 00:14